Overall Technical outlook

Price Summary

Piramal Pharma Limited's stock began trading at 197.0 on 2025-06-13, soared to 201.7, dipped to 195.56, and finished the day 1.63% up at 200.22, with 3331212 shares exchanged.
In the 52-week period, the stock's peak price is 293.55, and the lowest price recorded is 147.9.
Analysts expect the price of PPLPHARMA to vary between 255.0 and 340.0, with an average expected price near 296.0.

Technicals

Support and Resistance: The price sits at 200.22, supported by 190.75 and resisted by 201.82. This indicates a trading range where 190.75 provides a floor, preventing declines, and 201.82 acts as a ceiling, limiting further price increases for PPLPHARMA.
PPLPHARMA supportResistance babe5a
Support/Resistance for PPLPHARMA


Aroon: Aroon's bearish trend continues, with Aroon Down staying at the 100 level. This persistent downward pressure suggests further declines, but further analysis with other indicators is needed to confirm the trend's potential impact for Piramal Pharma Limited.
PPLPHARMA aroon babe5a
Aroon chart for Piramal Pharma Limited


Bol. Bands: The price for PPLPHARMA has moved below the lower Bollinger Band and has continued to stay beneath this level since the last shift. This situation signals potential overselling in the market, indicating strong downward momentum. The prolonged stay below the Bollinger Band suggests that the bearish trend is well-established, and without a reversal, the market might continue to experience pressure. This could be a critical point for traders to monitor.
PPLPHARMA bbands babe5a
Bolinger Bands chart for Piramal Pharma Limited


Parabolic SAR: The PSAR for PPLPHARMA continues to signal a bearish stance, reinforcing a resistance level that could restrict upward movement. This resistance suggests that the market may remain under bearish pressure, with limited potential for breaking higher.
PPLPHARMA psar babe5a
Parabolic Stop and Reverse chart for Piramal Pharma Limited


Stochastic: The STOCHASTIC is showing a neutral stance, not indicating a clear upward or downward trend for Piramal Pharma Limited. This suggests a period of market balance, where neither side is showing dominance.
PPLPHARMA stoch babe5a
Stochastic chart for Piramal Pharma Limited


Tripple Moving Agerage: The alignment of the 20-50-100 period moving averages suggests a bullish trend, but the potential for a reversal is hinted at by the slopes of the shorter-term averages. These faster-moving averages show signs of weakening momentum, indicating that while the overall trend is still upward, a reversal could be approaching.
PPLPHARMA trippleSMA babe5a
Tripple SMA chart for Piramal Pharma Limited


Before diving into the technical aspects of a company, such as stock price charts or volume trends, it's important to understand its fundamentals. These fundamentals include financial stability, growth potential, and strategic positioning. Additionally, knowing the broader industry landscape, including competitive pressures and regulatory factors, offers deeper insights. When this fundamental analysis is combined with technical indicators, it leads to more informed, accurate evaluations of the company's overall performance.